Nutrien (NTR)
(Delayed Data from NYSE)
$46.93 USD
+0.06 (0.13%)
Updated Nov 22, 2024 04:00 PM ET
After-Market: $47.11 +0.18 (0.38%) 7:58 PM ET
4-Sell of 5 4
B Value F Growth F Momentum D VGM
Price, Consensus and EPS Surprise
NTR 46.93 +0.06(0.13%)
Will NTR be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for NTR based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for NTR
Nutrien's Q3 Earnings and Revenues Fall Short of Estimates
Nutrien (NTR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
NTR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Nutrien (NTR) Q3 Earnings and Revenues Lag Estimates
Earnings Preview: ICL Group (ICL) Q3 Earnings Expected to Decline
Countdown to Nutrien (NTR) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Other News for NTR
BMO Says the S&P 500 Could Hit 6,700 in 2025 — Here Are 2 Stocks to Bet on It
NTR January 2025 Options Begin Trading
BlackRock Natural Resources Fund Q3 2024 Commentary
Analysts Have Conflicting Sentiments on These Materials Companies: Nutrien (NTR) and Corteva (CTVA)
More Thoughts On The Smith Maneuver - October Dividend Income Report